With just a few days before students head back to school, some parents are facing added stress due to a shortage of the potentially life-saving drug, EpiPen.
Back in May, the FDA declared a shortage of Mylan EpiPens and it’s generic version, citing manufacturing delays. Mylan does not manufacture the product, rather the product is manufactured by Meridian Medical Technologies, a Pfizer Company. However now more than three months later, there is no tentative time for when the supply will return.
“We’re seeing in some parts of the county pharmacists are actually splitting up a two pack, which is dangerous because rebound reactions can occur within minutes,” said Charleston mom, Kimberly Earl.
Earl told 13 News, “Its like one child takes this one and one child takes that one and they say come back when we get more but that is a really dangerous game to be playing.”
For kids like Matthew Miller, back to school requires extra precautions.
“I taught my friends how to use it so if I ever have a reaction they know what to do,” said Miller.
The shortage has forced many parents like Robyn Clark to make the switch from the EpiPen to other devices like the “Auvi-Q.”
However, many insurance companies don’t cover the other brands so often times parents must pay out of pocket.
“If they are paying retail, they are paying lots of money out of pocket,” said Clark. “A lot of money for a life saving drug that you need.”
If you or someone you know uses an epi-pen and is considering switching patients go over the training and ask the pharmacist for a demonstration.